1. Home
  2. Publications & Reports
  3. Policy Directives & Guidelines
  4. User-applied Labelling of Injectable Medicines, Fluids and Lines
Print this page Reduce font size Increase font size

User-applied Labelling of Injectable Medicines, Fluids and Lines

Doc type: Policy Directive
Compliance with this policy directive is mandatory.

Doc No.: PD2016_058

Functional Group - Sub Group:
Corporate Administration - Governance
Corporate Administration - Purchasing
Clinical/ Patient Services - Nursing and Midwifery
Clinical/ Patient Services - Medical Treatment
Population Health - Pharmaceutical

Summary
This Policy Directive sets out the requirements for user-applied labelling of injectable medicines, fluids and lines in NSW Public Health Organisations and NSW Ambulance.

Date of Publication: 22 December 2016

Replaces:

  • User applied Labelling of Injectable Medicines, Fluids and Lines [PD2012_007]
Author Branch: Clinical Excellence Commission

This document applies to: Local Health Districts, Board Governed Statutory Health Corporations, Chief Executive Governed Statutory Health Corporations, Specialty Network Governed Statutory Health Corporations, Affiliated Health Organisations, Community Health Centres, NSW Ambulance Service, Public Hospitals, NSW Health Pathology, Cancer Institute (NSW)

Audience: Clinical, administration staff

Distributed to: Public Health System, Divisions of General Practice, Health Associations Unions, NSW Ambulance Service , Ministry of Health, Public Hospitals, Private Hospitals and Day Procedure Centres , Tertiary Education Institutes

Review Date: 22 December 2021

Policy Manual: Not applicable

File No: 16/350

Status: Active

File link: User-applied Labelling of Injectable Medicines, Fluids and Lines
File size: 140Kb

User-applied Labelling of Injectable Medicines, Fluids and Lines

Print this page Reduce font size Increase font size